Cite
HARVARD Citation
Ricklefs, F. et al. (2022). DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Neuro-oncology. 24 (11), pp. 1886-1897. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ricklefs, F. et al. (2022). DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Neuro-oncology. 24 (11), pp. 1886-1897. [Online].